Wall Street Beat
Allergan says it stands by statements on Valeant
Breast implant maker Sientra sets IPO range
Breast implant maker Sientra set a price range for its planned initial public offering and raised the upper limit to $92 million, after filing in mid-September for an $86 million IPO.
GE CEO Immelt: Global experience got Flannery the top spot at GE Healthcare
5 factors affecting the future of medtech
Five disruptive factors playing out for the medical device industry will shape its course going forward, according to a report from consulting firm A.T. Kearney.
The report was culled from interviews with more than 30 executives from 20 companies spanning the medical device space, according to a press release.
Medtech VC deals post double-digit increases in Q3
Investors eye 3rd-quarter medical use from hospitals, insurers
Kimberly-Clark plans to spin out Halyard Health as a separately traded company | Medtech Wall Street news for the week of October 13, 2014
ConvaTec owners appoint banks to explore sale: sources
(Reuters) – ConvaTec‘s owners have appointed Morgan Stanley and Goldman Sachs to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said.